| Turning to highly-traded biotech stocks, Gilead Sciences, Inc.(NASDAQ:GILD) edged down despite analysts at RBC upped their PT on the stock to $50 from $44. Significantly, its latest price of $42.72 is at a premium of 31.83% to its 200-day moving ... See all stories on this topic » |  REM |
↧
Top Volume Biotech Stocks: Gilead Sciences (GILD), Affymax (AFFY), Amgen ... Alerts - "Gilead Sciences Inc"
↧